Pharmacokinetics in intralesional administration of recombinant Epidermal Growth Factor in patients with diabetic foot ulcers.
Phase of Trial: Phase I
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Recombinant epidermal growth factor (Primary)
- Indications Diabetic foot ulcer
- Focus Pharmacokinetics
- Sponsors Praxis Pharmaceuticals
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
- 14 Sep 2011 New trial record